QU organises engineering in medicine workshop

Qatar University College of Engineering's (QU-CENG) Department of Mechanical and Industrial Engineering (MIE) recently organised the 7th QU-Engineering in Medicine Workshop virtually under the theme Translating and Commercialising Biomedical Research from Lab to Products.
CENG associate dean for research and postgraduate programmes Prof Ahmed Masoud, keynote speakers, Prof Rayaz Malik (assistant dean for clinical investigations, WCM-Q and consultant endocrinology, Hamad Medical Corporation), Prof Sabu Thomas (former vice chancellor, Mahatma Gandhi University, India), and Prof Nureddin Ashammakhi (associate director, Center for Minimally Invasive Therapeutics, UCLA and MSU, US) and several speakers and attendees from different countries were present.
The aim was to bring together clinicians, scientists, engineers, and executives from various biomedical startup companies to share their experiences, recent advances, and ongoing activities in research and commercialising biomedical research products.
Dr Anwarul Hasan, associate professor at MIE-QU-CENG chaired the workshop. The speakers included Dr Reza Tafreshi (Texas A&M University at Qatar), Dr Rashad Alfkey (HMC), Dr Arghya Paul (Western University, Canada), Dr Mohamed Ghasemi Rad (Baylor College of Medicine, US), Dr Gozde Durmus (Stanford University, US), Prasanna Gore (CEO and co-founder of Syncell, US), Nihal Engin Vrana (CEO and co-founder of Spartha Medical, France), and many speakers from Qatar, Saudi Arabia, UAE, Oman, Turkey, Malaysia and beyond.
MIE head Prof Dr Saud Ghani said the event demonstrated that QU academics are pursuing high-quality multidisciplinary research and proving themselves to be at the forefront of their fields.
Dr Hasan pointed out that the workshop offered a unique perspective from experts in machine learning, AI, nanomedicine, drug delivery, ultrasound, imaging, immunotherapy, and biomedical product development which will be helpful in multidisciplinary research to bring novel innovative lifesaving products to the market.